A review of vancomycin therapeutic drug monitoring recommendations in Scotland | Zendy

Kristján Orri Helgason | Zendy; A H Thomson | Zendy; Christopher J. Ferguson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A review of vancomycin therapeutic drug monitoring recommendations in Scotland

Author(s) -

Kristján Orri Helgason,

A H Thomson,

Christopher J. Ferguson

Publication year - 2008

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkn114

Subject(s) - vancomycin , therapeutic drug monitoring , pharmacodynamics , pharmacokinetics , medicine , drug , pharmacology , intensive care medicine , biology , staphylococcus aureus , bacteria , genetics

Letter regarding the therapeutic monitoring of vancomycin. Most clinicians would agree that the analysis of peak concentrations is of limited value due to both the pharmacodynamic (time-dependency) and pharmacokinetic (multiexponential decline) properties of vancomycin.1 However, there is still a lack of uniformity with respect to trough concentrations

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research